{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:13:54Z","timestamp":1791756834486,"version":"4.3.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Ado-trastuzumab emtansine (T-DM1) is an antibody\u2013drug conjugate consisting of the monoclonal antibody trastuzumab linked to the maytansinoid DM1 with potential antineoplastic activity and is approved for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. An analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System identified 124\/1,243 (10%) renal adverse events for trastuzumab. However, there are no published case reports describing kidney biopsy findings related to nephrotoxicity of either trastuzumab or T-DM1. We report kidney biopsy findings in a case of nephrotic range proteinuria due to collapsing focal segmental glomerulosclerosis (FSGS) and tubular injury after initiation of T-DM1 therapy. After systematic exclusion of other causes, it is likely that the observed collapsing FSGS was associated with the prior initiation of T-DM1 therapy. This is further supported by the clinical course with improvement of proteinuria and kidney function 3 weeks after discontinuation of T-DM1 therapy without further specific treatment. In summary, we provide the first report of kidney biopsy findings in a case of nephrotic range proteinuria after initiation of T-DM1 therapy due to collapsing FSGS. This issue is especially relevant since T-DM1 is widely used, and nephrologists have to be aware of this potentially rare but severe complication.<\/jats:p>","DOI":"10.3389\/fonc.2021.796223","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:31:11Z","timestamp":1638365471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Samy","family":"Hakroush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1681\/ASN.2012070690","article-title":"Onconephrology: The Latest Frontier in the War Against Kidney Disease","volume":"24","author":"Salahudeen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ckj\/sft135","article-title":"Nephrotoxicity of Recent Anti-Cancer Agents","volume":"7","author":"Lameire","year":"2014","journal-title":"Clin Kidney J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/bcr3621","article-title":"Trastuzumab Emtansine: Mechanisms of Action and Drug Resistance","volume":"16","author":"Barok","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.esmoop.2021.100074","article-title":"The EMA Review of Trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Adult Patients With HER2-Positive Early Breast Cancer","volume":"6","author":"Delgado","year":"2021","journal-title":"ESMO Open"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.06.027","article-title":"Renal Effects of Novel Anticancer Targeted Therapies: A Review of the Food and Drug Administration Adverse Event Reporting System","volume":"90","author":"Jhaveri","year":"2016","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic Classification of Diabetic Nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft408","article-title":"Collapsing Glomerulopathy Superimposed on Diabetic Nephropathy: Insights Into Etiology of an Under-Recognized, Severe Pattern of Glomerular Injury","volume":"29","author":"Salvatore","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic Microangiopathy and the Kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.185","article-title":"Collapsing Glomerulopathy: A Clinically and Pathologically Distinct Variant of Focal Segmental Glomerulosclerosis","volume":"45","author":"Detwiler","year":"1994","journal-title":"Kidney Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11751111","article-title":"Collapsing Glomerulopathy in 19 Patients With Systemic Lupus Erythematosus or Lupus-Like Disease","volume":"7","author":"Salvatore","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.04.009","article-title":"AJKD Atlas of Renal Pathology: Collapsing Glomerulopathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00769.x","article-title":"Collapsing Glomerulopathy in HIV and non-HIV Patients: A Clinicopathological and Follow-Up Study","volume":"56","author":"Laurinavicius","year":"1999","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of Parvovirus B19 Infection With Idiopathic Collapsing Glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate Nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.10.010","article-title":"Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation","volume":"3","author":"Leal","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.07.021","article-title":"Collapsing Glomerulopathy Is Common in the Setting of Thrombotic Microangiopathy of the Native Kidney","volume":"90","author":"Buob","year":"2016","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00300106","article-title":"Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review","volume":"1","author":"Jaffe","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03590412","article-title":"Collapsing Glomerulopathy in Systemic Lupus Erythematosus: An Extreme Form of Lupus Podocytopathy","volume":"7","author":"Haas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040377","article-title":"How Does Proteinuria Cause Progressive Renal Damage","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.796223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:31:13Z","timestamp":1638365473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.796223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":20,"alternative-id":["10.3389\/fonc.2021.796223"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.796223","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"796223"}}